Contrary to claims of "socialized medicine," codifying President Trump's MFN policy prioritizes value over monopoly power.
Prescription Drugs
All Prescription Drugs
While Trump's strategy to lower prices is a step in the right direction, only Congress can deliver comprehensive reform that benefits all Americans
Our best ideas to bring innovative treatments to all Americans at a price they can afford
Plus: New York changes course on nuclear power; improving Medicare price negotiation; and the need for a coherent federal approach to K-12 education
Congress should strengthen the program to deliver lower drug costs to seniors and taxpayers
Attempts to lower drug prices leave intact a broken patent system that too often prioritizes profits over progress
The Inflation Reduction Act’s focus on high-grossing drugs leaves savings on the table
Plus: Should Boomers rent out their empty rooms?; will generative AI leave low-income workers behind?; and how to fix a wasteful health care subsidy